Cited by 3,806Immune cells in cancerInflammatory mediators and NSAID effectsCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 178 of the 178 references it cites were found in a registry or an index.

Inflammation and Cancer: Triggers, Mechanisms, and Consequences

Open access

Greten, Florian R., Grivennikov, Sergei I.·2019·Immunity

DOI 10.1016/j.immuni.2019.06.025PMC PMC6831096

Open this paper in CoChat — free account Open PDF

Abstract

Inflammation predisposes to the development of cancer and promotes all stages of tumorigenesis. Cancer cells, as well as surrounding stromal and inflammatory cells, engage in well-orchestrated reciprocal interactions to form an inflammatory tumor microenvironment (TME). Cells within the TME are highly plastic, continuously changing their phenotypic and functional characteristics. Here, we review the origins of inflammation in tumors, and the mechanisms whereby inflammation drives tumor initiation, growth, progression, and metastasis. We discuss how tumor-promoting inflammation closely resembles inflammatory processes typically found during development, immunity, maintenance of tissue homeostasis, or tissue repair and illuminate the distinctions between tissue-protective and pro-tumorigenic inflammation, including spatiotemporal considerations. Defining the cornerstone rules of engagement governing molecular and cellular mechanisms of tumor-promoting inflammation will be essential for further development of anti-cancer therapies.

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2019.06.025

Cites

178 of 178 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
Cancer-related inflammation
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Self-citation
Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018.
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Understanding the tumor immune microenvironment (TIME) for effective therapy
Binnewies, M., Roberts, E. W., Kersten, K., Chan, V., Fearon, D. F., Merad, M., Coussens, L. M., Gabrilovich, D. I., Ostrand-Rosenberg, S., Hedrick, C. C., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0014-x · Cited by 6,145
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632 · cited 2×
“However, inducers of TEI in microbial-rich versus “sterile” tumors may be different (Hanahan and Coussens, 2012; Mantovani et al., 2008).”
Background

Flagged first, then by citations

Show all 178 references

Sorted by citations

Items 501–600 of 1,001

Role of the tumor microenvironment in CLL pathogenesis
Stein, A. F. V., Hallek, M. J., & Nguyen, P. (2023) · Seminars in Hematology · doi:10.1053/j.seminhematol.2023.12.004 · Cited by 38
Intratumoral microbiota: implications for cancer onset, progression, and therapy
Wu, J., Zhang, P., Mei, W., & Zeng, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1301506 · Cited by 42
Intercellular adhesion molecule-1 (ICAM-1): From molecular functions to clinical applications in cancer investigation
Qian, W.-J., Yan, J., Gang, X., Xu, L., Shi, S., Li, X., Na, F., Cai, L.-T., Li, H., & Zhao, M. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189187 · Cited by 43
PAR2 deficiency enhances myeloid cell-mediated immunosuppression and promotes colitis-associated tumorigenesis
Ke, Z., Wang, C., Wu, T., Wang, W., Yang, Y., & Dai, Y. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.11.015 · Cited by 40
Nogo-B fosters HCC progression by enhancing Yap/Taz-mediated tumor-associated macrophages M2 polarization
Zhao, X., Wang, X., You, Y., Wen, D., Feng, Z., Zhou, Y., Que, K., Gong, J., & Liu, Z. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111979 · Cited by 39
Effect of Early-Stage Human Breast Carcinoma on Monocyte Programming
Patysheva, M. R., Larionova, I., Stakheyeva, M. N., Grigoryeva, E. S., Iamshchikov, P. S., Tarabanovskaya, N. A., Weiß, C., Kardashova, J., Frolova, A. A., Rakina, M. A., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.800235 · Cited by 40
The Mycobiome: Cancer Pathogenesis, Diagnosis, and Therapy
Gamal, A., Elshaer, M. Y. S., Alabdely, M. H., Kadry, A., McCormick, T. S., & Ghannoum, M. A. (2022) · Cancers · doi:10.3390/cancers14122875 · Cited by 42
Current Strategies of Photoacoustic Imaging Assisted Cancer Theragnostics toward Clinical Studies
Li, L., Li, S., Fan, Z., Huang, G., Tang, J., & Nie, L. (2022) · ACS Photonics · doi:10.1021/acsphotonics.2c00440 · Cited by 40
Impact of selenium nanoparticles in the regulation of inflammation
Raza, A., Johnson, H., Singh, A., & Sharma, A. K. (2022) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2022.109466 · Cited by 41
Aging is associated with increased chromatin accessibility and reduced polymerase pausing in liver
Bozukova, M., Nikopoulou, C., Kleinenkuhnen, N., Grbavac, D., Goetsch, K., & Tessarz, P. (2022) · Molecular Systems Biology · doi:10.15252/msb.202211002 · Cited by 41
The schedule of ATR inhibitor AZD6738 can potentiate or abolish antitumor immune responses to radiotherapy
Vendetti, F. P., Pandya, P., Clump, D. A., Schamus-Haynes, S., Tavakoli, M., diMayorca, M. S., Islam, N. M., Chang, J., Delgoffe, G. M., Beumer, J. H., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.165615 · Cited by 39
FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK-TAK1 signaling axis for the activation of NF-κB
Kim, M., ‍Kim, D. Y., Shin, J. H., Kang, Y., Lee, J. S., Son, J., Jeong, S., Kim, D., Kim, D.-H., Chun, E., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01038-y · Cited by 38
Poor oral health influences head and neck cancer patient survival: an International Head and Neck Cancer Epidemiology Consortium pooled analysis
Tasoulas, J., Farquhar, D. R., Sheth, S. H., Hackman, T., Yarbrough, W. G., Agala, C. B., Koric, A., Giraldi, L., Fabiánová, E., Lissowska, J., et al. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad156 · Cited by 39
The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances
Morcillo-Martín-Romo, P., Valverde-Pozo, J., Ortiz-Bueno, M., Arnone, M., Espinar‐Barranco, L., Espinar-Barranco, C., & García-Rubiño, M. E. (2025) · Biomedicines · doi:10.3390/biomedicines13040857 · Cited by 40
Gut microbiota derived indole-3-acetic acid ameliorates precancerous inflammatory intestinal milieu to inhibit tumorigenesis through IL-35
Wang, J., Yang, H., Yang, Y., Zhang, Y., Chen, X., & Yang, R. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-011155 · Cited by 43
Risk of cardiovascular disease among cancer survivors: systematic review and meta-analysis
Li, Q., Zhang, G., Li, X., Xu, S., Wang, H., Deng, J., Cheng, Z., Fan, F., Chen, S., Yang, M., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103274 · Cited by 39
A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer
Wang, K., Guan, C., Shang, X., Ying, X., Mei, S., Zhu, H., Xia, L., & Chai, Z. (2021) · Aging · doi:10.18632/aging.202601 · Cited by 39
Effect of Active Cancer on the Cardiac Phenotype: A Cardiac Magnetic Resonance Imaging‐Based Study of Myocardial Tissue Health and Deformation in Patients With Chemotherapy‐Naïve Cancer
Labib, D., Satriano, A., Dykstra, S., Hansen, R., Mikami, Y., Guzzardi, D. G., Slavíková, Z., Feuchter, P., Flewitt, J. A., Rivest, S. M., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.019811 · Cited by 39
The Prognostic Value of Preoperative Systemic Inflammatory Response Index (SIRI) in Patients With High-Grade Glioma and the Establishment of a Nomogram
He, Q., Li, L., & Ren, Q. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.671811 · Cited by 39
The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective
Phua, T. J. (2021) · Medicines · doi:10.3390/medicines8060030 · Cited by 39
Salivary Biomarkers in Lung Cancer
Skallevold, H. E., Vallenari, E. M., & Sapkota, D. (2021) · Mediators of Inflammation · doi:10.1155/2021/6019791 · Cited by 38
The Interplay Between Inflammation and Stromal Components in Pancreatic Cancer
Li, Y., Wang, J., Wang, H., Zhang, S., Wei, Y., & Liu, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.850093 · Cited by 40
Potent but transient immunosuppression of T-cells is a general feature of CD71+ erythroid cells
Grzywa, T. M., Sosnowska, A., Rydzyńska, Z., Łaźniewski, M., Plewczyński, D., Klicka, K., Małecka‐Giełdowska, M., Rodziewicz-Lurzyńska, A., Ciepiela, O., Justyniarska, M., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02914-4 · Cited by 39
Comprehensive analysis of pan‐cancer reveals potential of ASF1B as a prognostic and immunological biomarker
Hu, X., Zhu, H., Zhang, X., He, X., & Xu, X. (2021) · Cancer Medicine · doi:10.1002/cam4.4203 · Cited by 41
Plant-Based Diets and Cancer Risk: What is the Evidence?
DeClercq, V., Nearing, J. T., & Sweeney, E. (2022) · Current Nutrition Reports · doi:10.1007/s13668-022-00409-0 · Cited by 40
Gastric stem cells promote inflammation and gland remodeling in response to Helicobacter pylori via Rspo3‐Lgr4 axis
Wizenty, J., Müllerke, S., Kolesnichenko, M., Heuberger, J., Lin, M., Fischer, A., Mollenkopf, H., Berger, H., Tacke, F., & Sigal, M. J. (2022) · The EMBO Journal · doi:10.15252/embj.2021109996 · Cited by 37
IL-10 in cancer: an essential thermostatic regulator between homeostatic immunity and inflammation – a comprehensive review
Rallis, K. S., Corrigan, A. E., Dadah, H., Stanislovas, J., Zamani, P., Makker, S., Szabados, B. E., & Sideris, M. C. (2022) · Future Oncology · doi:10.2217/fon-2022-0063 · Cited by 45
Negative regulator NLRC3: Its potential role and regulatory mechanism in immune response and immune-related diseases
Sun, D., Xu, J., Zhang, W., Song, C., Gao, C., He, Y., & Shang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1012459 · Cited by 38
Senataxin and R-loops homeostasis: multifaced implications in carcinogenesis
Gatti, V., Domenico, S. D., Melino, G., & Peschiaroli, A. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01441-x · Cited by 38
Molecular Mechanisms of the Antitumor Effects of Mesalazine and Its Preventive Potential in Colorectal Cancer
Słoka, J., Madej, M., & Strzałka‐Mrozik, B. (2023) · Molecules · doi:10.3390/molecules28135081 · Cited by 38
Peripheral blood inflammatory indexes in breast cancer: A review
Xie, J., Guo, Z., Zhu, Y., Ma, M., & Jia, G. (2023) · Medicine · doi:10.1097/md.0000000000036315 · Cited by 42
Social and Biological Determinants in Lung Cancer Disparity
Brock, B. A., Mir, H., Flenaugh, E. L., Oprea‐Ilies, G., Singh, R., & Singh, S. (2024) · Cancers · doi:10.3390/cancers16030612 · Cited by 38
Ferroptosis and cuproptosis: Metal-dependent cell death pathways activated in response to classical chemotherapy – Significance for cancer treatment?
Kciuk, M., Gielecińska, A., Kałuzińska‐Kołat, Ż., Yahya, E. B., & Kontek, R. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189124 · Cited by 43
Dietary fibre counters the oncogenic potential of colibactin-producing Escherichia coli in colorectal cancer
Thakur, B. K., Malaisé, Y., Choudhury, S. R., Neustaeter, A., Turpin, W., Streutker, C., Copeland, J. K., Wong, E. O. Y., Navarre, W. W., Guttman, D. S., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-01938-4 · Cited by 46
The Role of Cancer-Elicited Inflammatory Biomarkers in Predicting Early Recurrence Within Stage II–III Colorectal Cancer Patients After Curable Resection
Liao, Y., Ying, H., Sun, F., Peng, H.-X., & Cheng, X. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s285129 · Cited by 38
Rational nanocarrier design towards clinical translation of cancer nanotherapy
Guo, D., Ji, X., & Luo, J. (2021) · Biomedical Materials · doi:10.1088/1748-605x/abe35a · Cited by 39
The Relationship between Serum Trace Elements and Oxidative Stress of Patients with Different Types of Cancer
Yang, Y., Dai, C.-M., Chen, X.-H., & Feng, J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4846951 · Cited by 38
Reinforcing the Combinational Immuno-Oncotherapy of Switching “Cold” Tumor to “Hot” by Responsive Penetrating Nanogels
Song, Q., Zhang, G., Wang, B., Cao, G., Li, D., Wang, Y., Zhang, Y., Geng, J., Li, H., & Li, Y. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c08201 · Cited by 39
STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis
Dawson, R., Deswaerte, V., West, A. C., Tang, K., West, A. J., Balic, J. J., Gearing, L. J., Saad, M. I., Yu, L., Wu, Y., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-323916 · Cited by 40
Phenylalanine-based poly(ester urea)s composite films with nitric oxide-releasing capability for anti-biofilm and infected wound healing applications
Li, M., Li, N., Qiu, W., Wang, Q., Jia, J., Wang, X., Yu, J., Li, X., Li, F., & Wu, D. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.10.016 · Cited by 38
Exploring the oncostatin M (OSM) feed-forward signaling of glioblastoma via STAT3 in pan-cancer analysis
Chen, M., Ren, R., Lin, W., Xiang, L., Zhao, Z., & Shao, B. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02260-9 · Cited by 38
Clinical significance of postoperative pulmonary complications in elderly patients with lung cancer
Okada, S., Shimomura, M., Ishihara, S., Ikebe, S., Furuya, T., & Inoue, M. (2022) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivac153 · Cited by 38
DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis
Kim, J., Park, S., Jeon, S.-E., Choi, J.-H., Lee, C.-J., Jang, T., Yun, H.-J., Lee, Y., Kim, P., Cho, S., et al. (2022) · Theranostics · doi:10.7150/thno.72037 · Cited by 38
Novel quinoxaline derivatives as dual EGFR and COX-2 inhibitors: synthesis, molecular docking and biological evaluation as potential anticancer and anti-inflammatory agents
Ahmed, E. A., Mohamed, M. F. A., & Omran, O. A. (2022) · RSC Advances · doi:10.1039/d2ra04498f · Cited by 38
Cancer immunoediting hypothesis: history, clinical implications and controversies
Lasek, W. (2022) · Central European Journal of Immunology · doi:10.5114/ceji.2022.117376 · Cited by 39
Licorice (Glycyrrhiza glabra L.)-Derived Phytochemicals Target Multiple Signaling Pathways to Confer Oncopreventive and Oncotherapeutic Effects
Tuli, H. S., Garg, V. K., Mehta, J. K., Kaur, G., Mohapatra, R. K., Dhama, K., Sak, K., Kumar, A., Varol, M., Aggarwal, D., et al. (2022) · OncoTargets and Therapy · doi:10.2147/ott.s366630 · Cited by 43
Targeting cancer-related inflammation with non-steroidal anti-inflammatory drugs: Perspectives in pharmacogenomics
Lai, H., Liu, Y., Wu, J., Cai, J., Hui, J., Xu, Y., & Deng, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1078766 · Cited by 37
IL-1β derived from mixed-polarized macrophages activates fibroblasts and synergistically forms a cancer-promoting microenvironment
Zhang, J., Fu, L., Yasuda‐Yoshihara, N., Yonemura, A., Wei, F., Bu, L., Hu, X., Akiyama, T., Kitamura, F., Yasuda, T., et al. (2022) · Gastric Cancer · doi:10.1007/s10120-022-01352-3 · Cited by 40
The Redox Protein High-Mobility Group Box 1 in Cell Death and Cancer
Chen, R., Zou, J., Kang, R., & Tang, D. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0236 · Cited by 39
The pharmacology and mechanisms of platycodin D, an active triterpenoid saponin from Platycodon grandiflorus
Xie, L., Zhao, Y., Zheng, Y., & Li, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1148853 · Cited by 37
Multifunctional Redox-Responsive Nanoplatform with Dual Activation of Macrophages and T Cells for Antitumor Immunotherapy
Zhang, W., Liu, X., Cao, S., Zhang, Q., Chen, X., Luo, W., Tan, J., Xu, X., Jing, T., Saw, P. E., et al. (2023) · ACS Nano · doi:10.1021/acsnano.2c12498 · Cited by 37
T cell senescence: a new perspective on immunotherapy in lung cancer
Huang, M., Wang, Y., Fang, L., Liu, C., Feng, F., Liu, L., & Sun, C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1338680 · Cited by 37
Allicin and Cancer Hallmarks
Talib, W. H., Baban, M. M., Azzam, A. O., Issa, J. J., Ali, A. Y., AlSuwais, A. K., Allala, S., & Kury, L. T. A. (2024) · Molecules · doi:10.3390/molecules29061320 · Cited by 37
Pattern-Recognition Receptors and Immunometabolic Reprogramming: What We Know and What to Explore
Kumar, V., & Stewart, J. H. (2024) · Journal of Innate Immunity · doi:10.1159/000539278 · Cited by 39
Autotaxin Implication in Cancer Metastasis and Autoimunne Disorders: Functional Implication of Binding Autotaxin to the Cell Surface
Peyruchaud, O., Saier, L., & Leblanc, R. (2019) · Cancers · doi:10.3390/cancers12010105 · Cited by 38
The active fraction of Garcinia yunnanensis suppresses the progression of colorectal carcinoma by interfering with tumorassociated macrophage‐associated M2 macrophage polarization in vivo and in vitro
Sui, H. X., Tan, H., Fu, J., Song, Q., Jia, R., Han, L., Lv, Y., Zhang, H., Zheng, D., Dong, L., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201903011r · Cited by 37
Identification of an immune gene signature for predicting the prognosis of patients with uterine corpus endometrial carcinoma
Zhou, C., Li, C., Yan, F., & Zheng, Y. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01560-w · Cited by 37
Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy
Shi, H., Li, K., Ni, Y., Liang, X., & Zhao, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.707198 · Cited by 39
Biology of cancer; from cellular and molecular mechanisms to developmental processes and adaptation
Motofei, I. G. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.10.003 · Cited by 40
HALP Score as a New Prognostic Index in Metastatic Renal Cell Cancer
Ekinci, F., Balçık, O. Y., Oktay, E., & Erdoğan, A. P. (2022) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2022.03.313 · Cited by 37
Cytokine chemokine network in tumor microenvironment: Impact on CSC properties and therapeutic applications
Nengroo, M. A., Verma, A., & Datta, D. B. (2022) · Cytokine · doi:10.1016/j.cyto.2022.155916 · Cited by 39
Neutrophil-albumin ratio as a biomarker for postoperative complications and long-term prognosis in patients with colorectal cancer undergoing surgical treatment
Xie, H., Wei, L., Liu, M., Liang, Y., Yuan, G., Gao, S., Wang, Q., Lin, X. H., Tang, S., & Gan, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.976216 · Cited by 37
Potential Pathophysiological Pathways in the Complex Relationships between OSA and Cancer
Sánchez‐de‐la‐Torre, M., Cubillos‐Zapata, C., Veatch, O. J., Rio, F. G., Gozal, D., & Martínez‐García, M. Á. (2023) · Cancers · doi:10.3390/cancers15041061 · Cited by 36
Cardiovascular disease and risk of lung cancer incidence and mortality: A nationwide matched cohort study
Wang, C., Lu, D., Cronin-Fenton, D. P., Huang, C. L., Liew, Z., Dang, W., Qin, G., Yu, Y., & Li, J. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.950971 · Cited by 36
A combination of pre-infusion serum ferritin, CRP and IL-6 predicts outcome in relapsed/refractory multiple myeloma patients treated with CAR-T cells
Liu, Y., Jie, X., Li, N., Wang, Y., Wang, C., Ma, J., Jiang, J., Wu, Q., Qiao, J., Chen, W., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1169071 · Cited by 36
Interleukins (Cytokines) as Biomarkers in Colorectal Cancer: Progression, Detection, and Monitoring
Maryam, S., Krukiewicz, K., Haq, I. U., Khan, A. A., Yahya, G., & Cavalu, S. D. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12093127 · Cited by 40
About a Possible Impact of Endodontic Infections by Fusobacterium nucleatum or Porphyromonas gingivalis on Oral Carcinogenesis: A Literature Overview
Ciani, L., Libonati, A., Dri, M., Pomella, S., Campanella, V., & Barillari, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105083 · Cited by 36
Metal- and covalent-organic framework-based drug delivery systems: Applications to control cell functions
Kang, M., Cho, Y., & Kim, T. P. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2024.216400 · Cited by 37
Molecular and Immunomodulatory Mechanisms of Statins in Inflammation and Cancer Therapeutics with Emphasis on the NF-κB, NLRP3 Inflammasome, and Cytokine Regulatory Axes
Khan, S., Huda, B., Bhurka, F., Patnaik, R., & Banerjee, Y. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178429 · Cited by 50
Circular RNA and tumor microenvironment
Song, H., Liu, Q., & Liao, Q. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01301-z · Cited by 37
The NLRP3 Inflammasome and Its Role in the Pathogenicity of Leukemia
Urwanisch, L., Luciano, M., & Horejs‐Hoeck, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031271 · Cited by 37
Licorice extract inhibits growth of non-small cell lung cancer by down-regulating CDK4-Cyclin D1 complex and increasing CD8+ T cell infiltration
Zhu, J., Huang, R., Yang, R., Xiao, Y., Yan, J., Zheng, C., Xiao, W., Huang, C., & Wang, Y. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02223-0 · Cited by 37
The Systemic Immune-Inflammation Index is an Independent Predictor of Survival in Breast Cancer Patients
Zhu, M., Chen, L., Kong, X., Wang, X., Li, X., Fang, Y., & Wang, J. (2022) · Cancer Management and Research · doi:10.2147/cmar.s346406 · Cited by 38
Global burden of cancers attributable to tobacco smoking, 1990–2019: an ecological study
Sharma, R., & Rakshit, B. (2022) · The EPMA Journal · doi:10.1007/s13167-022-00308-y · Cited by 37
Dioscin modulates macrophages polarization and MDSCs differentiation to inhibit tumorigenesis of colitis-associated colorectal cancer
Xun, J., Zhou, S., Lv, Z., Wang, B., Luo, H., Zhang, L., Yang, L., Zhang, A., Wu, X., Wang, Z., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109839 · Cited by 35
Dietary Patterns and Risk of Lung Cancer: A Systematic Review and Meta-Analyses of Observational Studies
Zhao, L., Kase, B. E., Zheng, J., & Steck, S. E. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00469-w · Cited by 37
Stimuli-responsive nanozymes for biomedical applications
Zhang, M., & Tong, W. (2023) · Biomaterials Science · doi:10.1039/d3bm00884c · Cited by 35
Telomerase and hallmarks of cancer: An intricate interplay governing cancer cell evolution
Kumar, N., & Sethi, G. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216459 · Cited by 35
The role of circadian clock in regulating cell functions: implications for diseases
Lin, Y., He, L., Cai, Y., Wang, X., Wang, S., & Li, F. (2024) · MedComm · doi:10.1002/mco2.504 · Cited by 38
Pathogenic mechanisms and latest therapeutic approaches for radiation-induced lung injury: A narrative review
Chang, S., Lv, J., Wang, X., Su, J., Bian, C., Zheng, Z., Yu, H., Bao, J., Xin, Y., & Jiang, X. M. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104461 · Cited by 38
Metabolic mechanisms orchestrated by Sirtuin family to modulate inflammatory responses
Li, X., Li, Y., Hao, Q., Jin, J., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1448535 · Cited by 37
Inflammation and Related Signaling Pathways in Acute Myeloid Leukemia
Naji, N. S., Sathish, M., & Karantanos, T. (2024) · Cancers · doi:10.3390/cancers16233974 · Cited by 38
Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence
Tufail, M., Jiang, C., & Li, N. (2025) · Military Medical Research · doi:10.1186/s40779-025-00595-2 · Cited by 50
The impact of ultra-processed foods on cardiovascular diseases and cancer: Epidemiological and mechanistic insights
Babalola, O. O., Akinnusi, E., Ottu, P. O., Bridget, K., Oyubu, G., Ajiboye, S. A., Adio, W. S., Amafili, C. C., Adebimpe, H. O., Nwokafor, C. V., et al. (2025) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2025.100072 · Cited by 49
Expression and Function of Eicosanoid-Producing Cytochrome P450 Enzymes in Solid Tumors
Evangelista, E. A., Cho, C. W., Aliwarga, T., & Totah, R. A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00828 · Cited by 35
Microvascular Venous Invasion in Hepatocellular Carcinoma: Why Do Recurrences Occur?
Isik, B., Gönültaş, F., Şahin, T. T., & Yılmaz, S. (2020) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-020-00487-9 · Cited by 35
The Effect of Inflammatory Markers on the Survival of Advanced Gastric Cancer Patients Who Underwent Anti-Programmed Death 1 Therapy
Qu, Z., Wang, Q., Wang, H., Jiao, Y., Li, M., Wei, W., Yu, L., Zhao, Z., Zhang, T., Zhang, Y., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.783197 · Cited by 37
Role of Prostaglandin E2 in the Progression of Gastrointestinal Cancer
Wilson, D. J., & DuBois, R. N. (2022) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-22-0038 · Cited by 35
Therapeutic Effects of Natural Products on Cervical Cancer: Based on Inflammatory Pathways
Zhou, Z., Long, H., Xu, S., Li, F., Cheng, Y., Luo, H., & Gao, L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.899208 · Cited by 39
Emergence of MUC1 in Mammals for Adaptation of Barrier Epithelia
Kufe, D. W. (2022) · Cancers · doi:10.3390/cancers14194805 · Cited by 35
Gut Microbiome Composition and Its Metabolites Are a Key Regulating Factor for Malignant Transformation, Metastasis and Antitumor Immunity
Lozenov, S., Krastev, B. M., Nikolaev, G., Peshevska-Sekulovska, M., Peruhova, M., & Velikova, T. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065978 · Cited by 35
Curcumin and analogues against head and neck cancer: From drug delivery to molecular mechanisms
Zhao, C., Zhou, X., Cao, Z., Ye, L., Cao, Y., & Pan, J. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154986 · Cited by 37
Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma
Fiorilla, I., Martinotti, S., Todesco, A. M., Bonsignore, G., Cavaletto, M., Patrone, M., Ranzato, E., & Audrito, V. (2023) · Cells · doi:10.3390/cells12162048 · Cited by 39
“Furthermore, another important kind of inflammation is therapy-induced inflammation, which progresses in response to various anti-neoplasm therapies, including radiotherapy, chemotherapy, and, recently, immunotherapies or biologic therapies, leading to a huge infiltration of immune cells [23].”
Background
CCDC137 Is a Prognostic Biomarker and Correlates With Immunosuppressive Tumor Microenvironment Based on Pan-Cancer Analysis
Guo, L., Li, B., Lu, Z., Liang, H., Yang, H., Chen, Y., Zhu, S., Zeng, M., Wei, Y., Liu, T., et al. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.674863 · Cited by 34
Hemoglobin/Red Blood Cell Distribution Width Ratio in Peripheral Blood Is Positively Associated with Prognosis of Patients with Primary Hepatocellular Carcinoma
Fang, Y., Sun, X., Zhang, L., Xu, Y., & Zhu, W. (2022) · Medical Science Monitor · doi:10.12659/msm.937146 · Cited by 34
Wnt Signaling in the Phenotype and Function of Tumor-Associated Macrophages
Tigue, M. L., Loberg, M. A., Goettel, J. A., Weiss, W. A., Lee, E. N., & Weiss, V. L. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1403 · Cited by 40
The role of perfluorooctane sulfonic acid (PFOS) exposure in inflammation of intestinal tissues and intestinal carcinogenesis
Durham, J., Tessmann, J. W., Deng, P., Hennig, B., & Zaytseva, Y. Y. (2023) · Frontiers in Toxicology · doi:10.3389/ftox.2023.1244457 · Cited by 35
Intestinal Microbiota Dysbiosis Promotes Mucosal Barrier Damage and Immune Injury in HIV‐Infected Patients
Pan, Z., Wu, N., & Jin, C. (2023) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2023/3080969 · Cited by 36
Immune Cell Migration to Cancer
Ryan, A. T., Kim, M., & Lim, K. (2024) · Cells · doi:10.3390/cells13100844 · Cited by 35
Reference-free inferring of transcriptomic events in cancer cells on single-cell data
Eralp, B., & Sefer, E. (2024) · BMC Cancer · doi:10.1186/s12885-024-12331-5 · Cited by 34

Authors: Greten, F. R., & Grivennikov, S. I.
Affiliations: Goethe University Frankfurt (DE)
Fox Chase Cancer Center (US)
Corresponding author: Greten, Florian R.
Grivennikov, Sergei I.
ORCID: Greten, Florian R.
Grivennikov, Sergei I.
Venue: Immunity
Publisher: Elsevier BV
Published: 2019-07
Volume: 51
Issue: 1
Pages: 27-41
ISSN: 1074-7613 (ISSN-L)
DOI: 10.1016/j.immuni.2019.06.025
PMC: PMC6831096
OpenAlex: W2959497269
Cited by: 3,806
References: 178
Citations by year: 2026: 457 · 2025: 640 · 2024: 753 · 2023: 715 · 2022: 664 · 2021: 397 · 2020: 163 · 2019: 16
FWCI: 26.79
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 381 d)
Locations: Immunity (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (R01CA227629, CA218133)
Pew Scholar in Biomedical Sciences
US-Israel BSF
NIH (P30 CA-006927)
Georg-Speyer-Haus
LOEWE Center Frankfurt Cancer Institute (III L 5 - 519/03/03.001 - (0015), FOR2438: Gr1916/11-1, SFB 815, 1177, 1292)
German Federal Ministry of Health
Ministry of Higher Education, Research and the Arts of the State of Hessen
Topics: Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords: tumor inflammation, tumor inflammatory microenvironment, carcinogenesis, tumor initiation, tumor progression, metastasis, tumor-stroma interactions, cellular plasticity, tissue homeostasis, tissue repair, cancer therapy
MeSH terms: Animals, Chronic Disease, Homeostasis, Humans, Infections, Inflammation, Neoplasms, Neovascularization, Pathologic, Wound Healing, Autoimmunity, Tumor Microenvironment, Carcinogenesis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inflammation and Cancer: Triggers, Mechanisms, and Consequences

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks